ES8500231A1 - Un metodo para preparar compuestos de piridilo - Google Patents

Un metodo para preparar compuestos de piridilo

Info

Publication number
ES8500231A1
ES8500231A1 ES523414A ES523414A ES8500231A1 ES 8500231 A1 ES8500231 A1 ES 8500231A1 ES 523414 A ES523414 A ES 523414A ES 523414 A ES523414 A ES 523414A ES 8500231 A1 ES8500231 A1 ES 8500231A1
Authority
ES
Spain
Prior art keywords
hydrogen
compounds
nitrogen
symptomatic treatment
allergic conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523414A
Other languages
English (en)
Other versions
ES523414A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8500231A1 publication Critical patent/ES8500231A1/es
Publication of ES523414A0 publication Critical patent/ES523414A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS DE PIRIDILO Y DE SUS SALES, ESTERES Y AMIDAS, DE FORMULA (I), EN LA QUE A, B, X Y R1-R4 PUEDEN SER VARIOS RADICALES.CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R5 ES UN ATOMO DE HALOGENO Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), CON UN COMPUESTO DE ALCOHIL-LITIO C1-6; SEGUIDA DE TRATAMIENTO CON DIOXIDO DE CARBONO.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIHISTAMINICA.
ES523414A 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo Granted ES523414A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8203261 1982-02-04
GB8229705 1982-10-18

Publications (2)

Publication Number Publication Date
ES8500231A1 true ES8500231A1 (es) 1984-10-01
ES523414A0 ES523414A0 (es) 1984-10-01

Family

ID=26281898

Family Applications (6)

Application Number Title Priority Date Filing Date
ES519491A Granted ES519491A0 (es) 1982-02-04 1983-02-03 Un metodo para preparar compuesto de piridilo.
ES523416A Expired ES8500233A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523418A Granted ES523418A0 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523414A Granted ES523414A0 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523417A Expired ES8500234A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523415A Expired ES8500232A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES519491A Granted ES519491A0 (es) 1982-02-04 1983-02-03 Un metodo para preparar compuesto de piridilo.
ES523416A Expired ES8500233A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523418A Granted ES523418A0 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES523417A Expired ES8500234A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo
ES523415A Expired ES8500232A1 (es) 1982-02-04 1983-06-20 Un metodo para preparar compuestos de piridilo

Country Status (32)

Country Link
EP (2) EP0085959B1 (es)
JP (2) JPS6479153A (es)
KR (6) KR880001466B1 (es)
AT (2) ATE64596T1 (es)
AU (1) AU555083B2 (es)
BG (6) BG42185A3 (es)
CA (2) CA1249830A (es)
CS (1) CS235306B2 (es)
CY (1) CY1627A (es)
DD (1) DD209446A5 (es)
DE (2) DE3379654D1 (es)
DK (1) DK164662C (es)
ES (6) ES519491A0 (es)
FI (1) FI82450C (es)
GB (1) GB2114565B (es)
GR (1) GR77407B (es)
HK (1) HK25892A (es)
HU (1) HU189223B (es)
IE (1) IE54600B1 (es)
IL (3) IL78419A (es)
MC (1) MC1498A1 (es)
NL (1) NL930057I2 (es)
NO (2) NO162556C (es)
NZ (1) NZ203171A (es)
PH (1) PH21348A (es)
PL (6) PL140708B1 (es)
PT (1) PT76192B (es)
SG (1) SG106091G (es)
SI (1) SI8310221A8 (es)
SU (1) SU1301312A3 (es)
UY (1) UY23404A1 (es)
YU (1) YU44821B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501893A (en) * 1982-02-04 1985-02-26 Findlay John W A 3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
US4610995A (en) * 1984-07-27 1986-09-09 Coker Geoffrey G Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
LU86387A1 (fr) * 1986-04-04 1987-12-07 Oreal Composes aromatiques,leur procede de preparation et leur utilisation en medicine humaine et veterinaire et en cosmetique
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
DE3711866A1 (de) * 1987-04-08 1988-10-27 Hoechst Ag Synthese von peptidamiden mittels festphasenmethode unter verwendung von saeurelabilen ankergruppen
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
DK0409406T3 (da) * 1989-06-19 1994-02-07 Wellcome Found Arylsubstituerede aminderivater, der er anvendelige ved cancerterapi
FR2711651B1 (fr) * 1993-10-28 1995-12-22 Adir Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US5420866A (en) * 1994-03-29 1995-05-30 Scientific-Atlanta, Inc. Methods for providing conditional access information to decoders in a packet-based multiplexed communications system
WO1997006167A1 (en) * 1995-08-05 1997-02-20 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
IT1277597B1 (it) 1995-09-15 1997-11-11 Smithkline Beecham Spa Derivati di diarilalchenilammina
CN101838235B (zh) * 2009-06-12 2013-08-07 重庆华邦制药有限公司 3-苯基-3'-吡啶基丙烯胺类化合物及其合成方法
US20140309244A1 (en) * 2010-09-23 2014-10-16 Syngenta Participations Ag Novel microbiocides
US20150139896A1 (en) 2012-04-23 2015-05-21 Saudi Basic Industries Corporation Solar energy based countinuous process and reactor system for the production of an alkene by dehydrogenation of the corresponding alkane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2567245A (en) * 1948-05-10 1951-09-11 Schering Corp Aryl-(2-pyridyl)-amino alkanes and their production
DE1227464B (de) * 1951-09-10 1966-10-27 Wellcome Found Verfahren zur Herstellung der trans-Form des neuen 1-(4'-Methylphenyl)-1-(2''-pyridyl)-3-pyrrolidinopropens-(1)
FR1228802A (fr) * 1954-05-03 1960-09-02 Farbwerke Hoechst Ag Vomals Me Procédé de préparation de composés tertio-amino-cétoniques
FR2197583B1 (es) * 1972-09-07 1975-10-17 Rhone Poulenc Ind

Also Published As

Publication number Publication date
PL140708B1 (en) 1987-05-30
KR870001916B1 (ko) 1987-10-22
NO830368L (no) 1983-08-05
DE3379654D1 (en) 1989-05-24
CA1275102A (en) 1990-10-09
KR840003628A (ko) 1984-09-15
PL140812B1 (en) 1987-05-30
NO162556B (no) 1989-10-09
AU555083B2 (en) 1986-09-11
PL141639B1 (en) 1987-08-31
BG42003A3 (en) 1987-09-15
KR870001927B1 (ko) 1987-10-22
NO874330L (no) 1983-08-05
BG41822A3 (en) 1987-08-14
EP0085959A2 (en) 1983-08-17
UY23404A1 (es) 1992-10-19
PL245841A1 (en) 1985-01-30
GR77407B (es) 1984-09-13
PL140809B1 (en) 1987-05-30
ES523415A0 (es) 1984-10-01
SU1301312A3 (ru) 1987-03-30
IL67829A0 (en) 1983-06-15
KR870001915B1 (ko) 1987-10-22
YU44821B (en) 1991-02-28
PL245842A1 (en) 1985-01-30
YU22183A (en) 1986-02-28
KR870001917B1 (ko) 1987-10-22
ES8500235A1 (es) 1984-10-01
PT76192A (en) 1983-03-01
CS235306B2 (en) 1985-05-15
IL78419A (en) 1989-01-31
ES523417A0 (es) 1984-10-01
NL930057I1 (nl) 1993-09-01
IE830213L (en) 1983-08-04
NO162556C (no) 1990-01-17
DK164662C (da) 1992-12-14
IL78419A0 (en) 1986-08-31
ES8403872A1 (es) 1984-04-01
GB2114565B (en) 1985-06-26
PL140810B1 (en) 1987-05-30
DK43683D0 (da) 1983-02-03
CA1275102C (es) 1990-10-09
DE3382321D1 (de) 1991-07-25
NO172341C (no) 1993-07-07
PL245845A1 (en) 1985-01-30
NZ203171A (en) 1986-12-05
PL240412A1 (en) 1985-01-30
BG42185A3 (en) 1987-10-15
PT76192B (en) 1986-01-24
ATE64596T1 (de) 1991-07-15
GB2114565A (en) 1983-08-24
CA1249830A (en) 1989-02-07
BG42004A3 (en) 1987-09-15
ES523416A0 (es) 1984-10-01
NO172341B (no) 1993-03-29
GB8302971D0 (en) 1983-03-09
ES519491A0 (es) 1984-04-01
DK43683A (da) 1983-08-05
PL245843A1 (en) 1985-01-30
EP0249950A1 (en) 1987-12-23
ES8500234A1 (es) 1984-10-01
HU189223B (en) 1986-06-30
FI82450B (fi) 1990-11-30
NO874330D0 (no) 1987-10-16
ES523418A0 (es) 1984-10-01
ES8500233A1 (es) 1984-10-01
EP0085959B1 (en) 1989-04-19
AU1098283A (en) 1983-08-11
FI830380A0 (fi) 1983-02-03
EP0249950B1 (en) 1991-06-19
KR880001466B1 (ko) 1988-08-11
CY1627A (en) 1992-07-10
EP0085959A3 (en) 1984-07-18
JPH0468B2 (es) 1992-01-06
PL140811B1 (en) 1987-05-30
JPH0251897B2 (es) 1990-11-08
JPH01301661A (ja) 1989-12-05
NL930057I2 (nl) 1994-02-16
FI830380L (fi) 1983-08-05
SG106091G (en) 1992-03-20
JPS6479153A (en) 1989-03-24
DD209446A5 (de) 1984-05-09
HK25892A (en) 1992-04-16
IL67829A (en) 1988-06-30
SI8310221A8 (en) 1995-10-31
FI82450C (fi) 1991-03-11
ES523414A0 (es) 1984-10-01
ATE42282T1 (de) 1989-05-15
BG41821A3 (en) 1987-08-14
IE54600B1 (en) 1989-12-06
DK164662B (da) 1992-07-27
MC1498A1 (fr) 1983-11-17
PL245844A1 (en) 1985-01-30
BG42005A3 (en) 1987-09-15
ES8500232A1 (es) 1984-10-01
KR870001918B1 (ko) 1987-10-22
PH21348A (en) 1987-10-13

Similar Documents

Publication Publication Date Title
ES8500231A1 (es) Un metodo para preparar compuestos de piridilo